Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
A multi-institutional investigation of psilocybin's effects on mouse behavior.Nature neuroscience · 2026-11-02Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study.CNS drugs · 2026-11-01Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophrenia.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-10-01Psilocybin restores social novelty investigation in male SAPAP3 knockout mice and engages prefrontal-hippocampal circuitry.Molecular psychiatry · 2026-09-17Factors Associated with Intentions to Use Psilocybin for Mental Health in Relation to Psychotherapy, Psychiatric Medications, and Natural/Synthetic Options.Journal of psychoactive drugs · 2026-09-01Psychedelics align brain activity with context.Nature · 2026-08-19Defining 'psychedelic'.Journal of psychopharmacology (Oxford, England) · 2026-08-17Psilocybin for Fear of Cancer RecurrenceSupportive Care in Cancer · 2026-08-01The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?Journal of Science Policy & Governance · 2026-07-02Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.JAMA psychiatry · 2026-07-01Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)Neurology · 2026-06-09Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic ActionCurrent Psychiatry Reports · 2026-06-05EE127 A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CAREValue in Health · 2026-06-01Retail Availability of Intoxicating Cannabis and Mushroom Products Across Eleven U.S. Cities: Sales Persist Despite Prohibitions.Journal of studies on alcohol and drugs · 2026-05-28PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under PsilocybinScientific Data · 2026-05-211020 Long-term Impact of Psilocybin Administration on Sleep-Continuity via Wearable Sensor Time-series: Preliminary-results in Post-Treatment Lyme DiseaseSLEEPJ · 2026-05-081080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral PowerSLEEPJ · 2026-05-08Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-07Human brain changes after first psilocybin useNature Communications · 2026-05-05“You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practiceDrugs Education Prevention and Policy · 2026-03-22Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers.BMJ open · 2026-03-12Psilocybin or Nicotine Patch for Smoking CessationJAMA Network Open · 2026-03-10Low-income group psilocybin assisted therapy for depression: An Oregon feasibility studyJournal of Psychedelic Studies · 2026-02-12Attitudes and perceptions of Portuguese mental health professionals on the therapeutic use of psilocybin and methylenedioxymethamphetamine (MDMA).Professional Psychology Research and Practice · 2026-02-01Oregon's Psilocybin Services: A Summary and Public Health Commentary.Health behavior research · 2026-01-01Wherefore the magic? The evolutionary role of psilocybin in naturebioRxiv · 2025-12-19Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.Molecular psychiatry · 2025-12-01Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.Psychedelic medicine (New Rochelle, N.Y.) · 2025-12-01Sex-specific role of the 5-HT receptor in psilocybin-induced extinction of opioid reward.Nature communications · 2025-11-20Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot study.Acta neuropsychiatrica · 2025-11-04Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.EClinicalMedicine · 2025-11-01With great power comes great responsibility: Promise and caution in the new psychedelic renaissanceBrain Disorders · 2025-09-23Adverse reactions among psychedelic users: Norwegian validation of the Challenging Experience Questionnaire.Journal of psychiatric research · 2025-09-01A lexicon for psychedelic research and treatmentDrug Science Policy and Law · 2025-08-31Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.Molecular psychiatry · 2025-07-01Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use DisorderPsyArXiv · 2025-06-10Low-Income Group Psilocybin Assisted Therapy for Depression: A Feasibility StudyClinicalTrials.gov · 2025-06-05Effects of Psilocybin on Mouse Brain Microstructure.AJNR. American journal of neuroradiology · 2025-06-03Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile AnalysisInternational Journal of Mental Health and Addiction · 2025-04-24Quantitative analysis of recreational psychoactive mushroom gummies in Portland, Oregon.Clinical toxicology (Philadelphia, Pa.) · 2025-04-01Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.The Journal of clinical psychiatry · 2025-03-03The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.Journal of affective disorders · 2025-03-01A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01Clinical Trial Comparing Psilocybin to Nicotine Patch for Tobacco AddictionDrug and Alcohol Dependence · 2025-02-01Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study.Journal of affective disorders · 2025-02-01Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study.Journal of psychoactive drugs · 2025-01-01Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled Study.Journal of clinical psychopharmacology · 2025-01-01: A new species from central Florida, with notes on and.Mycologia · 2025-01-01High hopes? Precision psychedelic addiction medicine.Frontiers in psychiatry · 2025-01-01The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.Journal of psychiatric research · 2024-12-01Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.Current psychiatry reports · 2024-11-01Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-10-09Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms.British journal of pharmacology · 2024-10-01Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocolWellcome Open Res · 2024-07-24Scanning the new frontier of mental health: psychedelic brain imagingThe Biochemist · 2024-03-14UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.BMJ open · 2024-03-14The Mystical Experience Questionnaire 4-Item and Challenging Experience Questionnaire 7-Item.Psychedelic medicine (New Rochelle, N.Y.) · 2024-03-01Development of a digital intervention for psychedelic preparation (DIPP).Scientific reports · 2024-02-19Changes in positive and negative affect in participants with treatment-resistant depression following COMP360 psilocybin treatmentNeuroscience Applied · 2024-01-01Investigational COMP360 psilocybin treatment for treatment-resistant depression: assessing altered states of consciousnessNeuroscience Applied · 2024-01-01Effect of oral tryptamines on the gut microbiome of rats-a preliminary study.PeerJ · 2024-01-01Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertension.Frontiers in psychiatry · 2024-01-01Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy Participants.Psychiatric research and clinical practice · 2024-01-01Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.Headache · 2024-01-01Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol.Wellcome open research · 2024-01-01Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations.Current biology: CB · 2023-12-04Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approachPsyArXiv · 2023-11-22Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain Injury.Military medicine · 2023-11-03Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin usePsyArXiv · 2023-10-14Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.JAMA · 2023-09-05Neuroimaging in psychedelic drug development: past, present, and future.Molecular psychiatry · 2023-09-01Psilocybin history, action and reaction: A narrative clinical review.Journal of psychopharmacology (Oxford, England) · 2023-09-01Transient Elevation of Plasma Glucocorticoids Supports Psilocybin-Induced Anxiolysis in Mice.ACS pharmacology & translational science · 2023-08-11Introduction to the chemistry and pharmacology of psychedelic drugsAustralian Journal of Chemistry · 2023-07-04Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal StudyPsyArXiv · 2023-06-09The evolution and ecology of psilocybin in nature.Fungal genetics and biology: FG & B · 2023-06-01Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis.Cureus · 2023-05-01Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.Journal of affective disorders · 2023-04-14509. Meta-Analysis of Functional Neuroimaging Studies of the Effects of Serotonergic Psychedelics on Neural ActivityBiological Psychiatry · 2023-04-09Microdosing psilocybin for chronic pain: a case series.Pain · 2023-04-01The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging StudiesEuropean Psychiatry · 2023-02-28Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.Journal of psychopharmacology (Oxford, England) · 2023-01-01Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report.Frontiers in psychiatry · 2023-01-01Assessing potential of psilocybin for depressive disorders.Expert opinion on investigational drugs · 2023-01-01Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests.Frontiers in psychiatry · 2023-01-01Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.Frontiers in psychiatry · 2023-01-01Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents.Scientific reports · 2022-12-19The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.Psychopharmacology · 2022-11-01Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality.Scientific reports · 2022-10-10Neuroimaging in psychedelic drug development: Past, present, and futurePsyArXiv · 2022-06-30Associations between classic psychedelics and nicotine dependence in a nationally representative sample.Scientific reports · 2022-06-22Development of an -based norbaeocystin production platform and evaluation of behavioral effects in rats.Metabolic engineering communications · 2022-06-01Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample.Scientific reports · 2022-04-07Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development.Fungal biology · 2022-04-01Increased global integration in the brain after psilocybin therapy for depression.Nature medicine · 2022-04-01Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study.Scientific reports · 2022-02-16Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.Journal of psychopharmacology (Oxford, England) · 2022-02-01Psychedelics and health behaviour change.Journal of psychopharmacology (Oxford, England) · 2022-01-01MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.Journal of psychopharmacology (Oxford, England) · 2022-01-01Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.Journal of psychopharmacology (Oxford, England) · 2022-01-01Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension.Journal of psychopharmacology (Oxford, England) · 2022-01-01Psychedelic Identity Shift: A Critical Approach to Set And Setting.Kennedy Institute of Ethics journal · 2022-01-01P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to musicEuropean Neuropsychopharmacology · 2021-12-01Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives.The American journal of drug and alcohol abuse · 2021-07-04Psychedelic science in post-COVID-19 psychiatry.Irish journal of psychological medicine · 2021-06-01Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.JAMA psychiatry · 2021-05-01Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case StudiesmedRxiv · 2021-04-07Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.Journal of psychopharmacology (Oxford, England) · 2021-04-01Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)PsyArXiv · 2021-03-24Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.Frontiers in pharmacology · 2021-01-01Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.EClinicalMedicine · 2020-10-01Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan.Psychopharmacology · 2020-08-01Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.Journal of psychopharmacology (Oxford, England) · 2020-02-01Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2020-02-01Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frameJournal of Contextual Behavioral Science · 2019-11-05Cessation and reduction in alcohol consumption and misuse after psychedelic use.Journal of psychopharmacology (Oxford, England) · 2019-09-01Hallucinogens and Their Therapeutic Use: A Literature Review.Journal of psychiatric practice · 2019-09-01Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.Experimental and clinical psychopharmacology · 2019-06-01Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.PloS one · 2019-01-01Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.Frontiers in psychiatry · 2019-01-01Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.Neuropharmacology · 2018-11-01The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.Neuropharmacology · 2018-11-01Effects of psilocybin therapy on personality structure.Acta psychiatrica Scandinavica · 2018-11-01Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.Psychopharmacology · 2018-10-01Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts.Journal of psychopharmacology (Oxford, England) · 2018-07-01Psilocybin and MDMA reduce costly punishment in the Ultimatum Game.Scientific reports · 2018-05-29T263. Psilocybin Improves Cognitive Control and Downregulates Parietal Cortex in Treatment-Seeking SmokersBiological Psychiatry · 2018-04-08Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.Psychopharmacology · 2018-02-01Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.Journal of psychopharmacology (Oxford, England) · 2018-01-01Neuroticism is associated with challenging experiences with psilocybin mushrooms.Personality and individual differences · 2017-10-15Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Scientific reports · 2017-10-13An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.Journal of psychopharmacology (Oxford, England) · 2017-07-01Potential Therapeutic Effects of Psilocybin.Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics · 2017-07-01Comparison of anomalous experiences after ingesting psilocybin mushrooms in research and non-research settingsDrug and Alcohol Dependence · 2017-01-21Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experienceDrug and Alcohol Dependence · 2017-01-21Long-term follow-up of psilocybin-facilitated smoking cessation.The American journal of drug and alcohol abuse · 2017-01-01Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.Journal of psychopharmacology (Oxford, England) · 2016-12-01The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.Journal of psychopharmacology (Oxford, England) · 2016-12-01Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.Journal of psychopharmacology (Oxford, England) · 2016-12-01Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.The international journal of neuropsychopharmacology · 2016-07-01Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accountsDrug and Alcohol Dependence · 2015-11-01Validation of the revised mystical experiences questionnaire in experimental sessions with psilocybinDrug and Alcohol Dependence · 2015-11-01Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.Journal of psychopharmacology (Oxford, England) · 2015-11-01Comparative phenomenology of psilocybin experiences in research and non-research settingsDrug and Alcohol Dependence · 2015-10-31Psilocybin, psychological distress, and suicidality.Journal of psychopharmacology (Oxford, England) · 2015-09-01Can psychedelic compounds play a part in drug dependence therapy?The British journal of psychiatry: the journal of mental science · 2015-01-01Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenologyDrug and Alcohol Dependence · 2014-12-16The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybinDrug and Alcohol Dependence · 2014-12-16Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.Journal of psychopharmacology (Oxford, England) · 2014-11-01Characterization of challenging experiences (i.e., bad trips) after ingesting psilocybinDrug and Alcohol Dependence · 2014-06-07Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot studyDrug and Alcohol Dependence · 2014-06-07Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.Current drug abuse reviews · 2014-01-01Broadband cortical desynchronization underlies the human psychedelic state.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2013-09-18Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.Journal for the scientific study of religion · 2012-12-01Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.Drug and alcohol dependence · 2012-06-01Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.Psychopharmacology · 2011-12-01Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.Journal of psychopharmacology (Oxford, England) · 2011-11-01Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in HumansPLoS ONE · 2010-12-01Other Times I Can Barely See: The Effects of Hallucinogens on Vision and AttentioneScholarship (California Digital Library) · 2009-12-31What geometric visual hallucinations tell us about the visual cortex.Neural computation · 2002-03-01